Funder
Natural Sciences and Engineering Research Council of Canada
University of Manitoba
Parkinson Society Canada
Publisher
Springer Science and Business Media LLC
Reference125 articles.
1. Williams-Gray CH, Mason SL, Evans JR, Foltynie T, Brayne C, Robbins TW, et al. The CamPaIGN study of Parkinson’s disease: 10-year outlook in an incident population-based cohort. J Neurol Neurosurg Psychiatry. 2013;84:1258–64.
2. Counsell C, Giuntoli C, Khan QI, Maple-Grødem J, Macleod AD. The incidence, baseline predictors, and outcomes of dementia in an incident cohort of Parkinson’s disease and controls. J Neurol. 2022;269:4288–98.
3. Fredericks D, Norton JC, Atchison C, Schoenhaus R, Pill MW. Parkinson’s disease and Parkinson’s disease psychosis: a perspective on the challenges, treatments, and economic burden. Fredericks D, editor. Am J Manag Care. 2017;23:S83–92.
4. Seppi K, Ray Chaudhuri K, Coelho M, Fox SH, Katzenschlager R, Perez Lloret S, et al. Update on treatments for nonmotor symptoms of Parkinson’s disease-an evidence-based medicine review. Mov Disord. 2019;34:180–98.
5. Litvan I, Goldman JG, Tröster AI, Schmand BA, Weintraub D, Petersen RC, et al. Diagnostic criteria for mild cognitive impairment in Parkinson’s disease: movement disorder society task force guidelines. Mov Disord. 2012;27:349–56.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Are the Nuclear Neuro-Imaging Biomarkers Reliable?;Nuclear Medicine and Molecular Imaging;2024-05-25